Identifying Changepoints in Biomarkers During the Preclinical Phase of Alzheimer’s Disease

Objective: Several models have been proposed for the evolution of Alzheimer’s disease (AD) biomarkers. The aim of this study was to identify changepoints in a range of biomarkers during the preclinical phase of AD. Methods: We examined nine measures based on cerebrospinal fluid (CSF), magnetic reson...

Descripción completa

Detalles Bibliográficos
Autores principales: Younes, Laurent, Albert, Marilyn, Moghekar, Abhay, Soldan, Anja, Pettigrew, Corinne, Miller, Michael I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6454004/
https://www.ncbi.nlm.nih.gov/pubmed/31001108
http://dx.doi.org/10.3389/fnagi.2019.00074

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6454004/
https://www.ncbi.nlm.nih.gov/pubmed/31001108
http://dx.doi.org/10.3389/fnagi.2019.00074

Ejemplares similares